CY 2018 Formulary-Level Cumulative Opioid Morphine Equivalent Dose (MED) Point-of-Sale (POS) Edit
Guidance for information regarding the template that Part D sponsors should utilize in the submission of the CY 2018 POS edit MED information to CMS via HPMS.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 18, 2017
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.